EUVIMEDEUVIMED entdecken
Scoping ReviewÜbersichtsarbeitOpen Access · CC BY 4.0

Application of Mechanistic Modeling to Support Dose‐Relevant Decision Making for CAR ‐T Cell Therapy in Oncology: A Systematic Scoping Review

Dolapo Odujinrin iD, Graham McClelland iD

Clinical and Translational Science · 2026-11 · 19 (11)

DOI: 10.1111/cts.70756 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical and Translational Science, online erschienen am 06.11.2026. Verfasst von Dolapo Odujinrin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Medicine Research, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, …. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Neoplasms, Receptors, Chimeric Antigen, Decision Support Systems, Clinical. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR‐T therapy has improved outcomes in selected relapsed or refractory hematologic malignancies. However, rational dose‐relevant decision application remains challenging because the administered (nominal) cell dose does not reliably predict in vivo exposure, toxicity, or clinical response. These relationships are not adequately characterized by empirical dose escalation alone. Mechanistic modeling may offer a biologically interpretable way to connect preclinical evidence and patient‐level CAR‐T posology, but its application remains incompletely defined. We conducted a systematic scoping review using JBI methodology and PRISMA‐ScR guidance, searching MEDLINE, Embase, Scopus, and Google Scholar (2010–2025). Eligible studies reported original CK/PD, PK/PD, QSP, PBPK/PD, stochastic, or agent‐based models for dose‐relevant application or regimen optimization. Nineteen studies met the inclusion criteria (13 mechanistic and 6 semi‐mechanistic models) spanning hematologic and solid‐tumor settings. Although these studies evaluated aspects of CAR‐T pharmacology, none provided prospectively validated clinical dose‐selection evidence. Overall, CAR‐T expansion appeared to be more influenced by tumor burden, antigen engagement, product‐specific attributes, lymphodepletion, and host or tumor‐site factors than by nominal dose. Solid‐tumor models highlighted delivery route, trafficking, biodistribution, and microenvironment barriers. Emerging in vivo CAR‐T platforms shifted dose considerations toward vector or mRNA dose and repeat dosing. Mechanistic modeling appears useful for framing CAR‐T dose‐relevant and regimen questions, but the current evidence is best interpreted as a taxonomy of model applications rather than proof of prospective clinical dose selection utility. Consistent with ICH M15 principles, future clinical, and regulatory application will require defined context of use, stronger validation, uncertainty assessment, and biological integration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveNeoplasmsReceptors, Chimeric AntigenDecision Support Systems, ClinicalModels, ImmunologicalAnimalsHumans

Stichwörter der Autor:innen

cancersdosemathematical modelingmechanism‐based pharmacokinetics‐pharmacodynamicsmodel‐based drug developmentmultiscale modelingquantitative pharmacologytranslational medicinetranslational pharmacokinetics‐pharmacodynamics

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Centre for Pharmaceutical Medicine Research, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

ORCID-Profile: Dolapo Odujinrin, Graham McClelland

Zitieren

APA

Odujinrin, D., & McClelland, G. (2026). Application of Mechanistic Modeling to Support Dose‐Relevant Decision Making for CAR ‐T Cell Therapy in Oncology: A Systematic Scoping Review. Clinical and Translational Science, 19(11). https://doi.org/10.1111/cts.70756

Vancouver

Odujinrin D, McClelland G. Application of Mechanistic Modeling to Support Dose‐Relevant Decision Making for CAR ‐T Cell Therapy in Oncology: A Systematic Scoping Review. Clinical and Translational Science. 2026;19(11). doi:10.1111/cts.70756

BibTeX
@article{Odujinrin2026,
  author = {Odujinrin, Dolapo and McClelland, Graham},
  title = {Application of Mechanistic Modeling to Support Dose‐Relevant Decision Making for CAR ‐T Cell Therapy in Oncology: A Systematic Scoping Review},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1111/cts.70756}
}
Kostenlos starten →